Company profile: DMC Biotechnologies
1.1 - Company Overview
Company description
- Provider of bio-based chemicals via fermentation, including L-alanine (reduces carbon emissions by 40–90%), xylitol (65% lower carbon footprint), flavor, fragrance and other ingredients, plus diols, polyols and organic acids for sustainable consumer goods. Offers Dynamic Metabolic Control Technology and precision fermentation for efficient, scalable, cost-effective commercialization with lower energy and resource use.
Products and services
- Dynamic Metabolic Control Technology: An industrial-grade platform that architects efficient, scalable fermentation, reducing energy and resource use to enable robust production of bio-based chemicals across commercial applications
- Precision Fermentation Process: A production-scale methodology engineered to address industry barriers, enabling rapid, cost-effective commercialization of bio-based chemicals through precision fermentation practices
- Biobased Chemicals: A commercial-grade portfolio including diols, polyols, and organic acids, produced via fermentation to supply sustainable consumer goods applications with lower-energy, resource-efficient bio-based components
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DMC Biotechnologies
Natural Industries
HQ: United States
Website
- Description: Provider of patented beneficial microorganisms for horticulture, agriculture, and lawn and garden applications, serving professional fruit, nut, vegetable, and ornamental growers in the United States and internationally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Industries company profile →
Isagro
HQ: Italy
Website
- Description: Provider of agropharmaceutical research, development, production and distribution, including xTrap, a pheromone-based insect trap with an 8Mp camera offered in Delta, Night, and Color versions, enabling insect population monitoring through image recognition and remote data access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isagro company profile →
LXP Group
HQ: Germany
Website
- Description: Provider of LX-Process technology that cracks 2G biomass, adaptable for large-scale 2G ethanol production and retrofit of smaller biogas plants. Offers LXP Plants for lignocellulosic pre-treatment to increase biogas yield, LXP Cellulose (C6/C5 sugars free of toxic inhibitors) for bioethanol/biogas and chemicals, high-purity LXP Lignin, end-to-end LXP plant development, and supply of sugar and lignin for biochemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LXP Group company profile →
LiquiGlide
HQ: United States
Website
- Description: Provider of permanently wet slippery surface technology that allows viscous liquids to slide effortlessly, as the first company to create such durable solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LiquiGlide company profile →
Kilfrost
HQ: Belgium
Website
- Description: Provider of aircraft de-icing fluids, manufacturing and supplying specialized aircraft de-icing and anti-icing products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kilfrost company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DMC Biotechnologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DMC Biotechnologies
2.2 - Growth funds investing in similar companies to DMC Biotechnologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DMC Biotechnologies
4.2 - Public trading comparable groups for DMC Biotechnologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →